- Home
- POOL vs ICLR Comparison
POOL vs ICLR Comparison
Compare POOL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- ICLR
- Stock Information
- Founded
- POOL 1993
- ICLR 1990
- Country
- POOL United States
- ICLR Ireland
- Employees
- POOL N/A
- ICLR N/A
- Industry
- POOL Industrial Specialties
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- POOL Consumer Discretionary
- ICLR Health Care
- Exchange
- POOL Nasdaq
- ICLR Nasdaq
- Market Cap
- POOL 11.6B
- ICLR 13.7B
- IPO Year
- POOL 1995
- ICLR 1998
- Fundamental
- Price
- POOL $301.64
- ICLR $186.33
- Analyst Decision
- POOL Hold
- ICLR Buy
- Analyst Count
- POOL 9
- ICLR 15
- Target Price
- POOL $346.43
- ICLR $210.64
- AVG Volume (30 Days)
- POOL 502.2K
- ICLR 983.8K
- Earning Date
- POOL 10-23-2025
- ICLR 10-22-2025
- Dividend Yield
- POOL 1.66%
- ICLR N/A
- EPS Growth
- POOL N/A
- ICLR 13.11
- EPS
- POOL 10.81
- ICLR 9.73
- Revenue
- POOL $5,276,415,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- POOL $1.98
- ICLR N/A
- Revenue Next Year
- POOL $3.67
- ICLR $1.42
- P/E Ratio
- POOL $27.91
- ICLR $19.17
- Revenue Growth
- POOL N/A
- ICLR N/A
- 52 Week Low
- POOL $282.22
- ICLR $125.10
- 52 Week High
- POOL $395.60
- ICLR $303.69
- Technical
- Relative Strength Index (RSI)
- POOL 36.89
- ICLR 57.64
- Support Level
- POOL $306.72
- ICLR $161.70
- Resistance Level
- POOL $313.71
- ICLR $197.05
- Average True Range (ATR)
- POOL 5.57
- ICLR 6.29
- MACD
- POOL -1.62
- ICLR 1.53
- Stochastic Oscillator
- POOL 2.85
- ICLR 65.86
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.